The University of Glasgow is playing a key role in a new cancer research network which will see the city become a world leader in the development of new treatments tailored for individual cancer patients.

Coordinated by Cancer Research UK, the new Glasgow Centre is Scotland’s final link in a unique chain of Cancer Research UK centres that are being launched across the country. It will help set the pace for national and international progress in cancer research.Professor Karen Vousden at CRUK Centre launch

The Cancer Research UK West of Scotland Cancer Centre will enable researchers who are not usually able to work together to exchange ideas and information more easily. The Centre will build collaborations to translate research into new ways to detect, understand and treat cancer.

The University of Glasgow is a UK leader in cancer research. From the work of the Beatson Institute, whose scientists study cancer cell behaviour, to the extensive clinical trials run by the University’s Institute of Cancer Sciences, the University boasts a large number of scientists and doctors all working in the field.

Along with the pioneering work being carried out at the Paul O’Gorman Leukaemia Research Centre and the soon-to-be-completed Beatson Translational Research Centre, Glasgow is at the forefront of developing a new understanding of cancer and developing new treatments for patients.

The new Centre will also help provide people in the West of Scotland with cutting-edge cancer treatment in state-of-the-art facilities, as well as help train the next generation of leaders in cancer research and cancer care.

Professor Karen Vousden, Director of the Beatson Institute for Cancer Research, and Director of the University of Glasgow’s Institute of Cancer Sciences, said: “This is a very exciting development for cancer research in Scotland. The new Centre will help us bring together a variety of researchers and clinicians to collaborate and work together to improve the lives of cancer patients across Scotland. By building closer links between scientists and doctors we want to increase the pace of research leading to improved treatments for people with cancer."

The Centre will draw together world class laboratory research and medical expertise from the University of Glasgow, the University of Strathclyde and NHS Greater Glasgow and Clyde to provide the best possible results for cancer patients nationwide.

Gary Nellies, 47 from Glasgow, was first diagnosed with bowel cancer in 2004. Gary said: “My surgeon told me that when she was operating on my bowel she noticed cysts on my liver. I had to recover from that surgery before I could do anything else. Ten weeks after my first operation I was back in and they removed a section of my liver.

“Shortly after my second operation my doctors noticed spots on my lungs and I was confirmed as having secondary tumours in my lungs. This was hard for me to take but I decided to do absolutely anything I could to deal with the situation.

“I have been able to take part in five different clinical trials since I was diagnosed. They give me the chance to try some potentially really exciting new treatments while also helping to increase our understanding of the disease. Four years ago I was told I may only have two years to live, so right now everything is a bonus and I’m so grateful for all the care and attention I’m getting.”

Gary said: “Cancer research is so important. It is really great news that Glasgow, where I am treated, is becoming a Cancer Research UK Centre. I’m so thankful for the incredible skills of everyone who is helping me through my cancer experience.”

The Centre will build on Glasgow’s world class research in the areas of drug discovery and how cancer spreads around the body. The focus will be on research into bowel cancer and chronic myeloid leukaemia, working to make new discoveries in basic cell biology then helping to translate those into new treatments.

Cancer Research UK already supports research in Glasgow. The grant to fund the new Centre is around £1million in the first year, bringing the charity’s total funding to more than £20 million a year in the city.

The vast majority of all of Scotland’s clinical trials in cancer are run in Glasgow, through the Clinical Trials Unit at the Beatson West of Scotland Cancer Centre.

Harpal Kumar, chief executive of Cancer Research UK, said: "Huge progress has been made in beating cancer since the charity was formed and we’re determined to save more lives. Funding these centres of excellence is one of the charity's priorities and will enable us to work towards the goals we have set to improve the treatment and survival of cancer patients. But we continue to welcome the generous donations we receive from the public to ensure we can build on what we have started today."


First published: 20 January 2011

<< January